This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pediatric Ophthalmology  • Alert me on articles by topic

Arch Ophthalmol. 2004;122:276-279.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Horner syndrome refers to a condition where oculosympathetic pathway damage or dysfunction can cause ptosis, miosis of the pupil, and anhydrosis.¹ Congenital Horner syndrome is most commonly idiopathic or due to a traumatic birth. Acquired Horner syndrome in children is often postsurgical. Other causes include neuroblastoma, trauma, and brainstem processes.²

The diagnosis of this condition may be confirmed by instilling topical cocaine in each eye. The Horner pupil dilates poorly in comparison with the healthy pupil.³

Apraclonidine hydrochloride is an -adrenergic receptor agonist that is approved for the treatment of elevated intraocular pressure following argon laser trabeculoplasty. A prior study⁴ of 6 adult patients with Horner syndrome showed that instillation of 1% apraclonidine into both eyes produced mydriasis in the affected eye only. In fact, all patients experienced a reversal of their baseline anisocoria. In every case, the miotic pupil on the Horner side dilated to become larger than the . . . [Full Text of this Article]

Report of Cases.


Comment.
Darron A. Bacal, MD
Milford, Conn

Susan R. Levy, MD
Guilford, Conn

Corresponding author and reprints: Darron A. Bacal, MD, Eye Physicians & Surgeons, PC, 202 Cherry St, Milford, CT 06460 (e-mail: kideyedoc2002@yahoo.com).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis
Koc et al.
Br. J. Ophthalmol. 2005;89:1442-1444.
ABSTRACT | FULL TEXT  

The Utility of 0.5% Apraclonidine in the Diagnosis of Horner Syndrome
Brown
Arch Ophthalmol 2005;123:578-578.
FULL TEXT